speb/financial-data huggingface dataset:
IX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2607637000000.00
IX balance_sheet (annual, 2025-03-31) — Payables: 392936000000.00
IX balance_sheet (quarterly, 2025-03-31) — Payables: 392936000000.00
IX balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 392936000000.00
IX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 392936000000.00
IX balance_sheet (annual, 2025-03-31) — Preferred Securities Outside Stock Equity: 3432000000.00
IX balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 3432000000.00
IX income_statement (annual, 2025-03-31) — Pretax Income: 480463000000.00
IX income_statement (quarterly, 2025-03-31) — Pretax Income: 97086000000.00
IX cash_flow (annual, 2025-03-31) — Purchase Of Business: -89871000000.00
IX cash_flow (annual, 2025-03-31) — Purchase Of Investment: -842155000000.00
IX cash_flow (annual, 2025-03-31) — Purchase Of PPE: -1357672000000.00
IX balance_sheet (annual, 2025-03-31) — Receivables: 2378190000000.00
IX balance_sheet (quarterly, 2025-03-31) — Receivables: 2378190000000.00
IX income_statement (annual, 2025-03-31) — Reconciled Depreciation: 399527000000.00
IX income_statement (annual, 2025-03-31) — Rent And Landing Fees: 394821000000.00
IX income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 101326000000.00
IX income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 394821000000.00
IX income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 101326000000.00
IX cash_flow (annual, 2025-03-31) — Repayment Of Debt: -1368479000000.00
IX cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: -53518000000.00
IX income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: -3750000000.00
IX balance_sheet (annual, 2025-03-31) — Retained Earnings: 3354911000000.00
IX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3354911000000.00
IX cash_flow (annual, 2025-03-31) — Sale Of Business: 111043000000.00
IX cash_flow (annual, 2025-03-31) — Sale Of Investment: 673891000000.00
IX cash_flow (annual, 2025-03-31) — Sale Of PPE: 373804000000.00
IX income_statement (annual, 2025-03-31) — Selling General And Administration: 1425628000000.00
IX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 359757000000.00
IX balance_sheet (annual, 2025-03-31) — Share Issued: 1162962244.00
IX balance_sheet (quarterly, 2025-03-31) — Share Issued: 1162962244.00
IX cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 50000000000.00
IX cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -98621000000.00
IX income_statement (annual, 2025-03-31) — Special Income Charges: 65522000000.00
IX income_statement (quarterly, 2025-03-31) — Special Income Charges: 21914000000.00
IX balance_sheet (annual, 2025-03-31) — Stockholders Equity: 4089782000000.00
IX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4089782000000.00
IX balance_sheet (annual, 2025-03-31) — Tangible Book Value: 4089782000000.00
IX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4089782000000.00
IX income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 117623793207.80
IX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 21714571616.92
IX income_statement (annual, 2025-03-31) — Tax Provision: 128828000000.00
IX income_statement (quarterly, 2025-03-31) — Tax Provision: 17150000000.00
IX income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.27
IX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.18
IX balance_sheet (annual, 2025-03-31) — Total Assets: 16866251000000.00
IX balance_sheet (quarterly, 2025-03-31) — Total Assets: 16866251000000.00
IX balance_sheet (annual, 2025-03-31) — Total Capitalization: 9822900000000.00
IX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 9822900000000.00
IX balance_sheet (annual, 2025-03-31) — Total Debt: 6282798000000.00
IX balance_sheet (quarterly, 2025-03-31) — Total Debt: 6282798000000.00
IX balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 4171783000000.00
IX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4171783000000.00
IX balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 12694468000000.00
IX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 12694468000000.00
IX balance_sheet (annual, 2025-03-31) — Total Tax Payable: 53149000000.00
IX balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 53149000000.00
IX income_statement (annual, 2025-03-31) — Total Unusual Items: 438677000000.00
IX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 122926000000.00
IX income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 438677000000.00
IX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 122926000000.00
IX balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 26672695.00
IX balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 26672695.00
IX balance_sheet (annual, 2025-03-31) — Treasury Stock: 61731000000.00
IX balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 61731000000.00
IX income_statement (quarterly, 2025-06-30) — +Total Revenue: 574482000000.00
IX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 314926000000.00
IX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 406777000000.00
IX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 234325000000.00
IX balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 3290297000000.00
IX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1133763077.00
IX income_statement (quarterly, 2025-06-30) — Basic EPS: 94.63
IX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 221111000000.00
IX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1206661000000.00
IX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 1322108000000.00
IX balance_sheet (quarterly, 2025-06-30) — Common Stock: 221111000000.00
IX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 4145509000000.00
IX balance_sheet (quarterly, 2025-06-30) — Current Debt: 629908000000.00
IX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 629908000000.00
IX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1133763077.00
IX income_statement (quarterly, 2025-06-30) — Diluted EPS: 94.44
IX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 107288000000.00
IX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 6308000000.00
IX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 16389000000.00
IX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 378458000000.00
IX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 358073000000.00
IX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2134644000000.00
IX income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 1004000000.00
IX balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 603625000000.00
IX income_statement (quarterly, 2025-06-30) — Insurance And Claims: 94237000000.00
IX income_statement (quarterly, 2025-06-30) — Interest Expense: 45362000000.00
IX income_statement (quarterly, 2025-06-30) — Interest Income: 87238000000.00
IX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 10526731000000.00
IX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 4605843000000.00
IX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 5751314000000.00
IX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 5751314000000.00
IX balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1315546000000.00
IX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 191236000000.00
IX balance_sheet (quarterly, 2025-06-30) — Minority Interest: 77937000000.00
IX income_statement (quarterly, 2025-06-30) — Minority Interests: -1983000000.00
IX balance_sheet (quarterly, 2025-06-30) — Net Debt: 5174561000000.00
IX income_statement (quarterly, 2025-06-30) — Net Income: 107288000000.00
IX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 107288000000.00
IX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 109271000000.00
IX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 107288000000.00
IX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 107288000000.00
IX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 109271000000.00
IX income_statement (quarterly, 2025-06-30) — Net Interest Income: 41876000000.00
IX balance_sheet (quarterly, 2025-06-30) — Net PPE: 2134644000000.00
IX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 4145509000000.00
IX income_statement (quarterly, 2025-06-30) — Normalized Income: 25583540416.77
IX income_statement (quarterly, 2025-06-30) — Operating Revenue: 574482000000.00
IX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1128752550.00
IX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 629908000000.00
IX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 378458000000.00
IX income_statement (quarterly, 2025-06-30) — Other Gand A: 164052000000.00
IX income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 83302000000.00
IX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1010000000.00
IX balance_sheet (quarterly, 2025-06-30) — Other Properties: 1943408000000.00
IX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 2013427000000.00
IX balance_sheet (quarterly, 2025-06-30) — Payables: 918551000000.00
IX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 918551000000.00
IX balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 3422000000.00
IX income_statement (quarterly, 2025-06-30) — Pretax Income: 155480000000.00
IX balance_sheet (quarterly, 2025-06-30) — Receivables: 2420204000000.00
IX income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 99784000000.00
IX income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 99784000000.00
IX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 3396279000000.00
IX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 358073000000.00
IX balance_sheet (quarterly, 2025-06-30) — Share Issued: 1162962244.00
IX income_statement (quarterly, 2025-06-30) — Special Income Charges: 5304000000.00
IX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 4145509000000.00
IX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 4145509000000.00
IX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 34551540416.77
IX income_statement (quarterly, 2025-06-30) — Tax Provision: 46209000000.00
IX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
IX balance_sheet (quarterly, 2025-06-30) — Total Assets: 17000280000000.00
IX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 9896823000000.00
IX balance_sheet (quarterly, 2025-06-30) — Total Debt: 6381222000000.00
IX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4223446000000.00
IX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 12776834000000.00
IX balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 603625000000.00
IX income_statement (quarterly, 2025-06-30) — Total Unusual Items: 116256000000.00
IX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 116256000000.00
IX balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 34209694.00
IX balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 84664000000.00
IX income_statement (quarterly, 2025-09-30) — +Total Revenue: 435615000000.00
IX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 317205000000.00
IX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 413144000000.00
IX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 235206000000.00
IX balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 689443000000.00
IX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 221111000000.00
IX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1275912000000.00
IX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 1395723000000.00
IX balance_sheet (quarterly, 2025-09-30) — Commercial Paper: 7200000000.00
IX balance_sheet (quarterly, 2025-09-30) — Common Stock: 221111000000.00
IX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4441677000000.00
IX balance_sheet (quarterly, 2025-09-30) — Current Debt: 609876000000.00
IX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 609876000000.00
IX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 163808000000.00
IX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 91890000000.00
IX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 20559000000.00
IX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 558624000000.00
IX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 397359000000.00
IX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2160738000000.00
IX income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 393000000.00
IX balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 675172000000.00
IX income_statement (quarterly, 2025-09-30) — Insurance And Claims: 126391000000.00
IX income_statement (quarterly, 2025-09-30) — Interest Expense: 48449000000.00
IX income_statement (quarterly, 2025-09-30) — Interest Income: 90112000000.00
IX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 10963025000000.00
IX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 4634010000000.00
IX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 5911472000000.00
IX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 5911472000000.00
IX balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 1240679000000.00
IX balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 192910000000.00
IX balance_sheet (quarterly, 2025-09-30) — Minority Interest: 80181000000.00
IX income_statement (quarterly, 2025-09-30) — Minority Interests: -1781000000.00
IX balance_sheet (quarterly, 2025-09-30) — Net Debt: 5245436000000.00
IX income_statement (quarterly, 2025-09-30) — Net Income: 163808000000.00
IX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 163808000000.00
IX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 165589000000.00
IX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 163808000000.00
IX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 163808000000.00
IX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 165589000000.00
IX income_statement (quarterly, 2025-09-30) — Net Interest Income: 41663000000.00
IX balance_sheet (quarterly, 2025-09-30) — Net PPE: 2160738000000.00
IX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4441677000000.00
IX income_statement (quarterly, 2025-09-30) — Normalized Income: 32243742913.20
IX income_statement (quarterly, 2025-09-30) — Operating Revenue: 435615000000.00
IX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1115245781.00
IX balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 602676000000.00
IX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 558624000000.00
IX income_statement (quarterly, 2025-09-30) — Other Gand A: 168902000000.00
IX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1411000000.00
IX balance_sheet (quarterly, 2025-09-30) — Other Properties: 1967828000000.00
IX balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2086405000000.00
IX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2703054000000.00
IX balance_sheet (quarterly, 2025-09-30) — Payables: 992377000000.00
IX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 992377000000.00
IX balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 48186000000.00
IX income_statement (quarterly, 2025-09-30) — Pretax Income: 236002000000.00
IX balance_sheet (quarterly, 2025-09-30) — Receivables: 2499549000000.00
IX income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 102066000000.00
IX income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 102066000000.00
IX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 3560087000000.00
IX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 397359000000.00
IX balance_sheet (quarterly, 2025-09-30) — Share Issued: 1162962244.00
IX income_statement (quarterly, 2025-09-30) — Special Income Charges: 91497000000.00
IX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4441677000000.00
IX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4441677000000.00
IX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 55944742913.20
IX income_statement (quarterly, 2025-09-30) — Tax Provision: 70413000000.00
IX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
IX balance_sheet (quarterly, 2025-09-30) — Total Assets: 17604283000000.00
IX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 10353149000000.00
IX balance_sheet (quarterly, 2025-09-30) — Total Debt: 6521348000000.00
IX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4521858000000.00
IX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 13082425000000.00
IX balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 675172000000.00
IX income_statement (quarterly, 2025-09-30) — Total Unusual Items: 187509000000.00
IX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 187509000000.00
IX balance_sheet (quarterly, 2025-09-30) — Trading Securities: 834000000.00
IX balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 47716463.00
IX balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 133351000000.00
IX income_statement (quarterly, 2025-12-31) — +Total Revenue: 552282000000.00
IX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 333720000000.00
IX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 473939000000.00
IX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 235187000000.00
IX balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 3382123000000.00
IX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 221111000000.00
IX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1307029000000.00
IX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 1420275000000.00
IX balance_sheet (quarterly, 2025-12-31) — Common Stock: 221111000000.00
IX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 4584992000000.00
IX balance_sheet (quarterly, 2025-12-31) — Current Debt: 691245000000.00
IX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 691245000000.00
IX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 118579000000.00
IX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 15517000000.00
IX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 25770000000.00
IX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 723439000000.00
IX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 420845000000.00
IX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2235876000000.00
IX income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 993000000.00
IX balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 720086000000.00
IX income_statement (quarterly, 2025-12-31) — Insurance And Claims: 133160000000.00
IX income_statement (quarterly, 2025-12-31) — Interest Expense: 50708000000.00
IX income_statement (quarterly, 2025-12-31) — Interest Income: 95274000000.00
IX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 11298376000000.00
IX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 4685125000000.00
IX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 6022139000000.00
IX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6022139000000.00
IX balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1303002000000.00
IX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 196857000000.00
IX balance_sheet (quarterly, 2025-12-31) — Minority Interest: 88287000000.00
IX income_statement (quarterly, 2025-12-31) — Minority Interests: -1977000000.00
IX balance_sheet (quarterly, 2025-12-31) — Net Debt: 5406355000000.00
IX income_statement (quarterly, 2025-12-31) — Net Income: 118579000000.00
IX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 118579000000.00
IX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 120556000000.00
IX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 118579000000.00
IX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 118579000000.00
IX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 120556000000.00
IX income_statement (quarterly, 2025-12-31) — Net Interest Income: 44566000000.00
IX balance_sheet (quarterly, 2025-12-31) — Net PPE: 2235876000000.00
IX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 4584992000000.00
IX income_statement (quarterly, 2025-12-31) — Normalized Income: 37265247950.20
IX income_statement (quarterly, 2025-12-31) — Operating Revenue: 552282000000.00
IX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1106829195.00
IX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 691245000000.00
IX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 723439000000.00
IX income_statement (quarterly, 2025-12-31) — Other Gand A: 183713000000.00
IX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 113000000.00
IX balance_sheet (quarterly, 2025-12-31) — Other Properties: 2039019000000.00
IX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 2135764000000.00
IX balance_sheet (quarterly, 2025-12-31) — Payables: 1053806000000.00
IX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1053806000000.00
IX balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 50545000000.00
IX income_statement (quarterly, 2025-12-31) — Pretax Income: 176237000000.00
IX balance_sheet (quarterly, 2025-12-31) — Receivables: 2609703000000.00
IX income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 103972000000.00
IX income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 103972000000.00
IX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 3573783000000.00
IX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 420845000000.00
IX balance_sheet (quarterly, 2025-12-31) — Share Issued: 1162962244.00
IX income_statement (quarterly, 2025-12-31) — Special Income Charges: 14524000000.00
IX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 4584992000000.00
IX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 4584992000000.00
IX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 37556247950.20
IX income_statement (quarterly, 2025-12-31) — Tax Provision: 55681000000.00
IX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.32
IX balance_sheet (quarterly, 2025-12-31) — Total Assets: 18125609000000.00
IX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 10607131000000.00
IX balance_sheet (quarterly, 2025-12-31) — Total Debt: 6713384000000.00
IX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 4673279000000.00
IX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 13452330000000.00
IX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 720086000000.00
IX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 118870000000.00
IX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 118870000000.00
IX balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 56133049.00
IX balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 168528000000.00
IX income_statement (annual, 2026-03-31) — +Total Revenue: 2168961000000.00
IX income_statement (quarterly, 2026-03-31) — +Total Revenue: 606582000000.00
IX balance_sheet (annual, 2026-03-31) — Accounts Payable: 356008000000.00
IX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 356008000000.00
IX balance_sheet (annual, 2026-03-31) — Accounts Receivable: 495905000000.00
IX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 495905000000.00
IX balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 235239000000.00
IX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 235239000000.00
IX cash_flow (annual, 2026-03-31) — Asset Impairment Charge: 16242000000.00
IX balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 782413000000.00
IX balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 782413000000.00
IX income_statement (annual, 2026-03-31) — Basic Average Shares: 1117160000.00
IX income_statement (annual, 2026-03-31) — Basic EPS: 400.27
IX cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1321983000000.00
IX cash_flow (annual, 2026-03-31) — Capital Expenditure: -1332435000000.00
IX balance_sheet (annual, 2026-03-31) — Capital Stock: 221111000000.00
IX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 221111000000.00
IX balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1334945000000.00
IX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1334945000000.00
IX balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1451099000000.00
IX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1451099000000.00
IX cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -170803000000.00
IX cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -160535000000.00
IX cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1114671000000.00
IX cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: 1369567000000.00
IX cash_flow (annual, 2026-03-31) — Change In Income Tax Payable: 25872000000.00
IX cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -39823000000.00
IX cash_flow (annual, 2026-03-31) — Change In Other Working Capital: 389059000000.00
IX cash_flow (annual, 2026-03-31) — Change In Payable: 26937000000.00
IX cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: 26937000000.00
IX cash_flow (annual, 2026-03-31) — Change In Receivables: 4556000000.00
IX cash_flow (annual, 2026-03-31) — Change In Tax Payable: 25872000000.00
IX cash_flow (annual, 2026-03-31) — Change In Working Capital: 380729000000.00
IX cash_flow (annual, 2026-03-31) — Changes In Account Receivables: 4556000000.00
IX cash_flow (annual, 2026-03-31) — Changes In Cash: 94361000000.00
IX balance_sheet (annual, 2026-03-31) — Commercial Paper: 3986000000.00
IX balance_sheet (quarterly, 2026-03-31) — Commercial Paper: 3986000000.00
IX balance_sheet (annual, 2026-03-31) — Common Stock: 221111000000.00
IX balance_sheet (quarterly, 2026-03-31) — Common Stock: 221111000000.00
IX cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -170803000000.00
IX balance_sheet (annual, 2026-03-31) — Common Stock Equity: 4482500000000.00
IX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4482500000000.00
IX cash_flow (annual, 2026-03-31) — Common Stock Payments: -150002000000.00
IX balance_sheet (annual, 2026-03-31) — Current Debt: 572235000000.00
IX balance_sheet (quarterly, 2026-03-31) — Current Debt: 572235000000.00
IX balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 572235000000.00
IX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 572235000000.00
IX cash_flow (annual, 2026-03-31) — Deferred Income Tax: 90387000000.00
IX cash_flow (annual, 2026-03-31) — Deferred Tax: 90387000000.00
IX cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 404791000000.00
IX cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 404791000000.00
IX income_statement (annual, 2026-03-31) — Diluted Average Shares: 1119852000.00
IX income_statement (annual, 2026-03-31) — Diluted EPS: 399.40
IX income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 447265000000.00
IX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 57590000000.00
IX cash_flow (annual, 2026-03-31) — Earnings Losses From Equity Investments: -123872000000.00
IX cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 34755000000.00
IX cash_flow (annual, 2026-03-31) — End Cash Position: 1451099000000.00
IX cash_flow (annual, 2026-03-31) — Financing Cash Flow: -160535000000.00
IX cash_flow (annual, 2026-03-31) — Free Cash Flow: 37132000000.00
IX cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -679000000.00
IX cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: -111311000000.00
IX cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -70115000000.00
IX income_statement (annual, 2026-03-31) — Gain On Sale Of Business: 111311000000.00
IX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Business: -2404000000.00
IX income_statement (annual, 2026-03-31) — Gain On Sale Of Security: 125360000000.00
IX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 62642000000.00
IX balance_sheet (annual, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 605110000000.00
IX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 605110000000.00
IX income_statement (annual, 2026-03-31) — General And Administrative Expense: 1603651000000.00
IX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 427374000000.00
IX balance_sheet (annual, 2026-03-31) — Gross PPE: 2229735000000.00
IX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2229735000000.00
IX income_statement (annual, 2026-03-31) — Impairment Of Capital Assets: 16242000000.00
IX income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 13852000000.00
IX balance_sheet (annual, 2026-03-31) — Income Tax Payable: 76733000000.00
IX balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 76733000000.00
IX income_statement (annual, 2026-03-31) — Insurance And Claims: 479937000000.00
IX income_statement (quarterly, 2026-03-31) — Insurance And Claims: 126149000000.00
IX income_statement (annual, 2026-03-31) — Interest Expense: 193889000000.00
IX income_statement (quarterly, 2026-03-31) — Interest Expense: 49370000000.00
IX income_statement (annual, 2026-03-31) — Interest Income: 365570000000.00
IX income_statement (quarterly, 2026-03-31) — Interest Income: 92946000000.00
IX balance_sheet (annual, 2026-03-31) — Invested Capital: 11020494000000.00
IX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 11020494000000.00
IX cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1114671000000.00
IX balance_sheet (annual, 2026-03-31) — Investments And Advances: 4615141000000.00
IX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 4615141000000.00
IX cash_flow (annual, 2026-03-31) — Issuance Of Debt: 1210761000000.00
IX balance_sheet (annual, 2026-03-31) — Long Term Debt: 5965759000000.00
IX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 5965759000000.00
IX balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5965759000000.00
IX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5965759000000.00
IX cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 1210761000000.00
IX cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -1217574000000.00
IX balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 1306312000000.00
IX balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 1306312000000.00
IX balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 325412000000.00
IX balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 325412000000.00
IX balance_sheet (annual, 2026-03-31) — Minority Interest: 90568000000.00
IX balance_sheet (quarterly, 2026-03-31) — Minority Interest: 90568000000.00
IX income_statement (annual, 2026-03-31) — Minority Interests: -11063000000.00
IX income_statement (quarterly, 2026-03-31) — Minority Interests: -5322000000.00
IX cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -89340000000.00
IX cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: -150002000000.00
IX balance_sheet (annual, 2026-03-31) — Net Debt: 5203049000000.00
IX balance_sheet (quarterly, 2026-03-31) — Net Debt: 5203049000000.00
IX income_statement (annual, 2026-03-31) — Net Income: 447265000000.00
IX income_statement (quarterly, 2026-03-31) — Net Income: 57590000000.00
IX income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 447265000000.00
IX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 57590000000.00
IX income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 458328000000.00
IX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 62912000000.00
IX income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 447265000000.00
IX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 57590000000.00
IX income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 447265000000.00
IX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 57590000000.00
IX cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 458328000000.00
IX income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 458328000000.00
IX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 62912000000.00
IX income_statement (annual, 2026-03-31) — Net Interest Income: 171681000000.00
IX income_statement (quarterly, 2026-03-31) — Net Interest Income: 43576000000.00
IX cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 107603000000.00
IX cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -6386000000.00
IX cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -6813000000.00
IX cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -8898000000.00
IX cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -12037000000.00
IX balance_sheet (annual, 2026-03-31) — Net PPE: 2229735000000.00
IX balance_sheet (quarterly, 2026-03-31) — Net PPE: 2229735000000.00
IX cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -979944000000.00
IX cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 427000000.00
IX balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 4482500000000.00
IX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 4482500000000.00
IX balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 611051000000.00
IX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 611051000000.00
IX balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 611051000000.00
IX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 611051000000.00
IX income_statement (annual, 2026-03-31) — Normalized Income: 90799735000.00
IX income_statement (quarterly, 2026-03-31) — Normalized Income: -11422000000.00
IX cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1369567000000.00
IX cash_flow (annual, 2026-03-31) — Operating Gains Losses: -304313000000.00
IX income_statement (annual, 2026-03-31) — Operating Revenue: 2168961000000.00
IX income_statement (quarterly, 2026-03-31) — Operating Revenue: 606582000000.00
IX balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 1098586820.00
IX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1098586820.00
IX balance_sheet (annual, 2026-03-31) — Other Current Borrowings: 568249000000.00
IX balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 568249000000.00
IX balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: 605110000000.00
IX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 605110000000.00
IX income_statement (annual, 2026-03-31) — Other Gand A: 711775000000.00
IX income_statement (quarterly, 2026-03-31) — Other Gand A: 195108000000.00
IX cash_flow (annual, 2026-03-31) — Other Non Cash Items: 289386000000.00
IX income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: -58803000000.00
IX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -58515000000.00
IX balance_sheet (annual, 2026-03-31) — Other Properties: 1904323000000.00
IX balance_sheet (quarterly, 2026-03-31) — Other Properties: 1904323000000.00
IX balance_sheet (annual, 2026-03-31) — Other Receivables: 2152820000000.00
IX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 2152820000000.00
IX balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 2526416000000.00
IX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 2526416000000.00
IX balance_sheet (annual, 2026-03-31) — Payables: 432741000000.00
IX balance_sheet (quarterly, 2026-03-31) — Payables: 432741000000.00
IX balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 432741000000.00
IX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 432741000000.00
IX balance_sheet (annual, 2026-03-31) — Preferred Securities Outside Stock Equity: 50743000000.00
IX balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 50743000000.00
IX income_statement (annual, 2026-03-31) — Pretax Income: 691431000000.00
IX income_statement (quarterly, 2026-03-31) — Pretax Income: 123712000000.00
IX cash_flow (annual, 2026-03-31) — Purchase Of Business: -129036000000.00
IX cash_flow (annual, 2026-03-31) — Purchase Of Investment: -668837000000.00
IX cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1332435000000.00
IX balance_sheet (annual, 2026-03-31) — Receivables: 2648725000000.00
IX balance_sheet (quarterly, 2026-03-31) — Receivables: 2648725000000.00
IX income_statement (annual, 2026-03-31) — Reconciled Depreciation: 404791000000.00
IX income_statement (annual, 2026-03-31) — Rent And Landing Fees: 411939000000.00
IX income_statement (quarterly, 2026-03-31) — Rent And Landing Fees: 106117000000.00
IX income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 411939000000.00
IX income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 106117000000.00
IX cash_flow (annual, 2026-03-31) — Repayment Of Debt: -1217574000000.00
IX cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -150002000000.00
IX income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 0.00
IX balance_sheet (annual, 2026-03-31) — Retained Earnings: 3502509000000.00
IX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3502509000000.00
IX cash_flow (annual, 2026-03-31) — Sale Of Business: 39696000000.00
IX cash_flow (annual, 2026-03-31) — Sale Of Investment: 776440000000.00
IX cash_flow (annual, 2026-03-31) — Sale Of PPE: 352491000000.00
IX income_statement (annual, 2026-03-31) — Selling General And Administration: 1603651000000.00
IX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 427374000000.00
IX balance_sheet (annual, 2026-03-31) — Share Issued: 1124106624.00
IX balance_sheet (quarterly, 2026-03-31) — Share Issued: 1124106624.00
IX income_statement (annual, 2026-03-31) — Special Income Charges: 95069000000.00
IX income_statement (quarterly, 2026-03-31) — Special Income Charges: -16256000000.00
IX balance_sheet (annual, 2026-03-31) — Stockholders Equity: 4482500000000.00
IX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4482500000000.00
IX balance_sheet (annual, 2026-03-31) — Tangible Book Value: 4482500000000.00
IX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4482500000000.00
IX income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 181189735000.00
IX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 46008000000.00
IX income_statement (annual, 2026-03-31) — Tax Provision: 233103000000.00
IX income_statement (quarterly, 2026-03-31) — Tax Provision: 60800000000.00
IX income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.34
IX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
IX balance_sheet (annual, 2026-03-31) — Total Assets: 18002776000000.00
IX balance_sheet (quarterly, 2026-03-31) — Total Assets: 18002776000000.00
IX balance_sheet (annual, 2026-03-31) — Total Capitalization: 10448259000000.00
IX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 10448259000000.00
IX balance_sheet (annual, 2026-03-31) — Total Debt: 6537994000000.00
IX balance_sheet (quarterly, 2026-03-31) — Total Debt: 6537994000000.00
IX balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 4573068000000.00
IX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4573068000000.00
IX balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 13429708000000.00
IX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 13429708000000.00
IX balance_sheet (annual, 2026-03-31) — Total Tax Payable: 76733000000.00
IX balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 76733000000.00
IX income_statement (annual, 2026-03-31) — Total Unusual Items: 537655000000.00
IX income_statement (quarterly, 2026-03-31) — Total Unusual Items: 115020000000.00
IX income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 537655000000.00
IX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 115020000000.00
IX balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 25519804.00
IX balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 25519804.00
IX balance_sheet (annual, 2026-03-31) — Treasury Stock: 81469000000.00
IX balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 81469000000.00
IX1.DE cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 5148000.00
IX1.DE balance_sheet (annual, 2021-12-31) — Foreign Currency Translation Adjustments: -61999000.00
IX1.DE balance_sheet (annual, 2021-12-31) — Hedging Assets Current: 6512000.00
IX1.DE balance_sheet (annual, 2021-12-31) — Minimum Pension Liabilities: 0.00
IX1.DE balance_sheet (annual, 2021-12-31) — Minority Interest: 0.00
IX1.DE income_statement (annual, 2021-12-31) — Minority Interests: 1000.00
IX1.DE cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 73500000.00
IX1.DE balance_sheet (annual, 2021-12-31) — Unrealized Gain Loss: -126000.00
IX1.DE income_statement (annual, 2022-12-31) — +Operating Expense: 1105573000.00
IX1.DE income_statement (annual, 2022-12-31) — +Total Revenue: 3367324000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 110221000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 400619000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -705914000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1463215000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -8265000.00
IX1.DE cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 2346000.00
IX1.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 83623000.00
IX1.DE income_statement (annual, 2022-12-31) — Basic EPS: 8.12
IX1.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 144454000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 356049000.00
IX1.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -158838000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 121664000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 10719000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 112546000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 112546000.00
IX1.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -370936000.00
IX1.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -195350000.00
IX1.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 542984000.00
IX1.DE cash_flow (annual, 2022-12-31) — Change In Account Payable: 3467000.00
IX1.DE cash_flow (annual, 2022-12-31) — Change In Inventory: -121731000.00
IX1.DE cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -113868000.00
IX1.DE cash_flow (annual, 2022-12-31) — Change In Payable: 3467000.00
IX1.DE cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 3467000.00
IX1.DE cash_flow (annual, 2022-12-31) — Change In Receivables: -41398000.00
IX1.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: -273530000.00
IX1.DE cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -41398000.00
IX1.DE cash_flow (annual, 2022-12-31) — Changes In Cash: -23302000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Common Stock: 10719000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 608737000.00
IX1.DE cash_flow (annual, 2022-12-31) — Common Stock Payments: -819711000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Construction In Progress: 97310000.00
IX1.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 1362986000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 221696000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Current Assets: 1101477000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 20425000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Current Debt: 653982000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 674407000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 50776000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 37938000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 37938000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 1235803000.00
IX1.DE cash_flow (annual, 2022-12-31) — Deferred Income Tax: -35065000.00
IX1.DE cash_flow (annual, 2022-12-31) — Deferred Tax: -35065000.00
IX1.DE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 111900000.00
IX1.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 111900000.00
IX1.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 84600000.00
IX1.DE income_statement (annual, 2022-12-31) — Diluted EPS: 8.03
IX1.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 679089000.00
IX1.DE income_statement (annual, 2022-12-31) — EBIT: 899830000.00
IX1.DE income_statement (annual, 2022-12-31) — EBITDA: 1011730000.00
IX1.DE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -8606000.00
IX1.DE cash_flow (annual, 2022-12-31) — End Cash Position: 112546000.00
IX1.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -370936000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Finished Goods: 246986000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -87691000.00
IX1.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 384146000.00
IX1.DE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -77796000.00